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Pathophysiology
A seizure occurs when a large group of neurons undergo excessive, abnormal
synchronized electrical discharge (depolarization) within the CNS; depolarization
is the result of influx of sodium ions into neuronal cells, whereas repolarization
occurs when potassium ions are pumped out of the cells creating the normal
negative electrical potential across the cell membrane. This electrical potential is
maintained by a sodium-potassium pump, which requires ATP as its energy source.
Excessive depolarization is generally felt to be the end common pathway by which
seizures occur. Hypoxia-ischemia, the most common cause of neonatal seizures,
results in a sharp decrease in energy production, causing a failure of the sodium-
potassium pump.
Classification of neonatal seizures
Neonatal seizures are difficult both to identify and to classify. Most seizures in
the neonate are focal, the features being subtle and not easily recognizable. Also,
newborns rarely have generalized tonic-clonic seizures or partial seizures with
rapid secondary generalization. The several types of neonatal seizures as described
by Volpe (1) are subtle seizures, clonic seizures( focal or multifocal), tonic seizures,
and myoclonic seizures.
Subtle seizures
Subtle seizures are more common in full term than in premature infants. Subtle
seizures, such as bicycling movments, lip smacking, roving eye movements, and
apnea, are seen more commonly in preterm than in term infants. The most common
manifestations of subtle seizures in both preterm and full term infants are ocular
movements (1-3); in full term infants, there is usually horizontal sustained deviation
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of the eyes, whereas in preterm infants, the ictal
manifestation is most commonly sustained eye opening,
with unresponsiveness and ocular fixation. Other
examples include chewing or other oral-buccal lingual
movements, pedaling or other stereotypic limb
movements, autonomic phenomena, and apneic spells.
Video EEG studies have demonstrated that most subtle
seizures are not associated with electrographic seizures
(4, 5).
Clonic seizures
Clonic seizures can either be focal or multifocal. These
movements, most commonly associated with
electrographic seizures, often involve one extremity or
one side of the body. The rhythm of the clonic movements
is usually slow, 1-3 movements per second. These seizures
are more typically seen in term infants than in preterm
infants.
Tonic seizures
Tonic seizures represent a mixed group-some are probably
secondary to brain stem injury/dysfunction, whereas
others have distinct EEG correlates on surface EEG
monitoring. These may involve one extremity or the
whole body; focal tonic seizures involving one extremity
often are associated with electrographic seizures.
Myoclonic seizures
Myoclonic seizures are seen in both preterm and term
infants and may occur focally in one extremity or in
several body parts( multifocal myoclonic seizures).
They may or may not have EEG correlates. If the
myoclonus is related to sleep or hypoxic – ischemic
injury, there is usually no EEG correlate (1, 2, 4). Focal
and multifocal myoclonic seizures typically are not
associated with electrographic correlates.
Jitteriness
Jitteriness must be differentiated from seizures in neonates,
because of the following features:
•Jitteriness is not associated with ocular deviation
•It is stimulus sensitive (eg, easily stopped with passive
movement of the limb)
•The movement resembles a tremor, and no autonomic
changes are associated with it.
Etiology of newborn seizures
The most common etiology of neonatal seizures is
perinatal hypoxia-ischemia. With hypoxic- ischemic
encephalopathy (HIE), the seizures usually begin within
the first 24 hours after birth and are associated with
obtundation. Seizures may be seen in both term and
preterm infants and may include subtle, clonic, or
generalized seizures. Other common etiologies include
intracranial infections and intracranial hemorrhage.
Intracranial hemorrhage occurs more frequently in
premature than in term infants, and is estimated to account
for approximately 10% of all neonatal seizures (4, 6, 7).
Metabolic disturbances can also cause neonatal seizures.
The most common metabolic etologies for neonatal
seizures include hypoglycemia, hypocalcemia, and
hypomagnesaemia (8). Hypernatremia and hyponatremia,
although less common, can also produce seizures in the
neonatal period. Less frequent metabolic disorders, such
as inborn errors of metabolism, are seen more commonly
in infants aged over 72 hours. They may be seen after
the infant starts feeding; if there is no evidence of HIE,
sepsis, or hemorrhage, metabolic diseases must then be
considered. Metabolic disorders that can result in neonatal
seizures include aminoacidopathies, urea cycle disorders,
biothinidase deficiency, mitochondrial disorders, defects
in beta-oxidation, glucose transporter deficiency, and
peroxisomal disorders. Pyridoxine dependency, a defect
in pyridoxine metabolism, although a rare disorder,
produces severe seizures in the neonatal period that are
resistant to antiepileptic drug therapy (9-12).  in the
neonatal period, most cerebral malformation can present
with seizures Familial neonatal convulsions usually begin
on the second or third day of life and can be either partial
or generalized(13,14). The seizures disappear by the age
of 2-6 months. A family history of seizures is common.
Development is typically normal in these infants; seizures
are associated with behavioral arrest, eye deviation to
one side, and tonic stiffening, sometimes myoclonic
jerks.
Benign sleep myoclonus is a condition, occurring only
during sleep, in which rhythmic movements mimic
seizures. Video EEG monitoring shows no electrographic
seizures. Benign idiopathic, neonatal seizures typically
present on the fifth day of life, i.e. “fifth day fits”; they
occur in full-term infants and can appear to be quite
fulminant, occurring up to 15-20 times per day; infants
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otherwise appear healthy. The seizures are usually clonic
and are sometimes associated with apnea and cyanosis.
Two severe, catastrophic epileptic syndromes have also
been identified during the neonatal period; Ohtahara’s
syndrom and early myoclonic encephalopathy fit easily
into the category of neonatal generalized epileptic
syndromes. Both begin in the neonatal period, usually in
the first 10 days after birth. Children with these
encephalopathies suffer from severe neurological diseases,
with developmental delays and intractable seizures (15-
17).
Work up
History: Documenting the clinical history provides
important clues to the likely etiology of neonatal seizures;
a family history of convulsions, genetic disorders,
pregnancy history (fetal distress, preeclampsia, maternal
infections), delivery history (type of delivery, antecedent
events, Apgar scores, resuscitation), and postnatal history
(drug withdrawal, neonatal hypocalcemia, infection)
should be obtained.
Physical exam: Infants with neonatal seizures are
frequently lethargic between seizures and often appear
ill. Findings of the neurological examination between
seizures may be normal.
Lab studies:
Serum electrolytes:  Serum glucose, Calcium, and Mg
should be measured; the severity of the neurological
symptoms is directly correlated with the duration of the
metabolic disturbance.
CSF analysis: This should include tests checking for
pleocytosis, protein, and glucose concentration, gram
stain and culture, xanthocromia, lactic acid and pyrovate
and sometimes PCR for the herpes virus. Lethargy,
vomiting, temperature instability, or subtle changes in
physiologic homeostasis usually identify sepsis. Any
infant with these symptoms should have a sepsis work
up, including blood, urine and CSF cultures.
Metabolic investigations: Inborn errors of metabolism
are relatively rare causes of seizures in the neonatal
population, however, if there is no evidence of HIE, sepsis,
or hemorrhage, metabolic diseases must then be
considered. Metabolic investigations should include
evaluations of blood lactate, pyruvate, ammonia,
quantitative aminoacids, and very long-chain fatty acids,
urine-quantitative organic acids and CSF cell count,
pyruvate, lactate , glucose( with simultaneous plasma
glucose).Disturbances of amino acid or organic acid
metabolism are often the most common inborn errors of
metabolism that present with neonatal seizures.
Renal function tests:  These tests rule out post- hypoxic
renal function.
Imaging studies
Cranial ultrasound:  Cranial ultrasound is easily performed
at the bedside; it is a valuable tool that quickly identifies
intracranial hemorrhage, particularly intraventricular
hemorrhage.
Cranial C.T scan: Cranial C.T scan is a much more
sensitive tool than ultrasound in detecting parenchymal
abnormalities; the only disadvantage is that the sick
neonate must be transported to the imaging site.
MRI: Cranial MRI is the most sensitive test in determining
the etiology of neonatal seizures. A major disadvantage
is that it cannot be performed quickly.
EEG: EEG plays a vital role in properly identifying and
differentiating neonatal seizures from non epileptic
seizures. Surface video EEG monitoring has also
demonstrated that many electrographic seizures in the
newborn are not accompanied by any observable clinical
phenomena and are probably underestimated.
Treatment:
The single most important factor in determining treatment
of neonatal seizures is identification of the underlying
etiology for the seizures. Acute neonatal seizures should
be treated aggressively. When clinical seizures are present,
a work up to determine an underlying etiologic cause
should be initiated quickly. Treatment of neonatal seizures
begins with the understanding that both seizures and their
subsequent therapy may be associated with changes in
respiration, heart rate, and blood pressure. Thus, to manage
these changes, therapeutic strategies must be developed
that ensure an adequate airway and access to circulatory
system early in the course of treatment. Etiologic therapy
such as treatment of hypoglycemia, hypocalcemia, and
hypomagnessemia and CNS infections is critical since it
may prevent further brain injury.  Furthermore, these
seizures may not be effectively controlled with antiepileptic
drugs (AED) unless their underlying cause is treated.
Hypoglycemia: Hypoglycemia should be corrected
immediately with a 10 percent glucose solution given
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intravenously at 2 ml/kg. Maintenance glucose infusion
can be given to a maximum of 8mg/kg per minute. It is
imperative to avoid hyperglycemia.
Hypocalcemia: Hypocalcemia associated with severe
neuromuscular irritability or seizures is treated with 10
percent calcium- gluconate (100mg/kg or 1ml/kg IV).
The solution is infused over 5-10 minutes, while heart
rate and infusion site are closely being monitored. The
dose can be repeated in 10 minutes if no response occurs.
Hypomagnesemia: Neonatal hypomagnesemia is often
associated with hypocalcemia, although it can occur
alone. The treatment is 50 percent solution of magnesium
sulfate injected intra-muscularly at 50 mg/kg. The same
dose can be repeated every 12 hours until
normomagnesemia is achieved.
Pyridoxin dependency: Pyridoxin (100 mg IV) is often
used empirically during EEG monitoring in infants with
refractory seizures, and can have a dramatically beneficial
effect on those with pyridoxine dependency.
Antiepileptic therapy
After initial management of airway and cardiovascular
support, and the identification and institution of etiologic-
specific therapy, the physician must decide whether to
initiate antiepileptic drug (AED) therapy and which AED
to use.
Phenobarbital: Phenobarbital is given as a loading dose
of 20 mg/kg intravenously within 10 to 15 minutes. It
can also be given intramuscularly in case there is no
venous access. If there is no response within 15 minutes,
5mg /kg Phenobarbital can be given every 5 minutes
until seizure activity ceases completely or until a total
loading dose of 40mg/kg is given. If the seizure is
controlled, then we put the patient on the maintenance
dose of 3-5 mg/kg, given orally, intravenously or
intramuscularly in two divided doses. In infants with
hypoxic-ischemic encephalopathy, the total loading dose
should not be more than 20 mg/kg since they have poor
hepatic metabolism of the medication and high doses
may cause toxicity in these infants.
Phenytoin: If there is no response to the loading dose of
Phenobarbital, phenytoin in a loading dose of 20 mg/kg
can be given intravenously within 15-20 minutes. The
maintenance dose of this drug is 3-5 mg/kg given orally
or intravenously. Since this drug is precipitated in dextrose
water, we should wash the I.V line with normal saline
before giving this medication. Obtaining the serum drug
levels of both Phenobarbital and phenytoin is
recommended.
Other AEDs:
Lorazepam: Given intravenously 0.05-0.1 mg /kg
Diazepam: Given intravenously 0.1-0.3 mg /kg within
5 minutes or 0.2- 0.8 mg /kg/hr  as continuous IV Infusion.
Midazolam: Given intravenously 0.03-0.1 mg/kg stat,
then 0.05 mg /kg/hr as continous IV infusion.
Duration of AED therapy:
    * In most cases if the infant is receiving both
phenobarbital and phenytoin, the latter can be discontinued
before hospital discharge.
     * If the seizure is the result of a Transient problem
such as hypoglycemia or hypocalcaemia, the
anticonvulsion drug can be stopped before discharge.
    * In the case of normal neurological status of the
infant, medication can be stopped during the neonatal
period.
    * If the neurological exam is abnormal, we should
continue the medication until the electroencephalogram,
imaging studies (MRI, brain C T scan, sonography) and
neurodevelopmental assessment are normal which may
be up to two to three and sometimes up to twelve months
after discharge.
Prognosis and outcome of neonatal seizures:
Prognosis is determined by etiology of neonatal seizures.
The EEG is also important in determining the outcome.
If the seizure is due to a transient condition such as
hypocalcemia,.... the prognosis is good. If EEG
background is normal, the prognosis is excellent for
seizures to resolve. Severe EEG background abnormalities
indicate poor prognosis, since such patients frequently
have epilepsy.
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